{"id":376437,"date":"2022-01-02T06:32:02","date_gmt":"2022-01-02T09:32:02","guid":{"rendered":"http:\/\/acaopopular.net\/jornal\/?p=376437"},"modified":"2022-01-02T06:32:02","modified_gmt":"2022-01-02T09:32:02","slug":"russia-vai-comercializar-spray-nasal-contra-covid-19-em-ate-quatro-meses","status":"publish","type":"post","link":"https:\/\/acaopopular.net\/jornal\/russia-vai-comercializar-spray-nasal-contra-covid-19-em-ate-quatro-meses\/","title":{"rendered":"R\u00fassia vai comercializar spray nasal contra covid-19 em at\u00e9 quatro meses"},"content":{"rendered":"<h2 class=\"article__headline marginBottom30\"><\/h2>\n<div class=\"article__lead\">\n<p><strong>Produto ser\u00e1 eficiente contra a variante \u00f4micron, diz Alexander Gintsburg, diretor do Instituto Gamaleya<\/strong><\/p>\n<\/div>\n<div class=\"articleMetadata marginBottom30\"><\/div>\n<figure><picture><source srcset=\"https:\/\/publisher-publish.s3.eu-central-1.amazonaws.com\/pb-brasil247\/swp\/jtjeq9\/media\/20211229201244_bc6ecd16e4ea8bdffb0e8b5980b8d2466136c0af1e466e345d0edb606044a895.webp\" type=\"image\/webp\" media=\"(max-width: 680px)\" \/><source srcset=\"https:\/\/publisher-publish.s3.eu-central-1.amazonaws.com\/pb-brasil247\/swp\/jtjeq9\/media\/20211229201244_bc6ecd16e4ea8bdffb0e8b5980b8d2466136c0af1e466e345d0edb606044a895.png\" type=\"image\/png\" media=\"(max-width: 680px)\" \/><source srcset=\"https:\/\/publisher-publish.s3.eu-central-1.amazonaws.com\/pb-brasil247\/swp\/jtjeq9\/media\/20211229201244_af5be3ee339e9d67db3742161ab05dd2f3d358bf8c3575b8c642caf72091a59d.webp\" type=\"image\/webp\" media=\"(min-width: 681px)\" \/><source srcset=\"https:\/\/publisher-publish.s3.eu-central-1.amazonaws.com\/pb-brasil247\/swp\/jtjeq9\/media\/20211229201244_af5be3ee339e9d67db3742161ab05dd2f3d358bf8c3575b8c642caf72091a59d.png\" type=\"image\/png\" media=\"(min-width: 681px)\" \/><img decoding=\"async\" title=\"Alexander Gintsburg (Foto: Evgeniy Odinokov\/POOL\/TASS)\" src=\"https:\/\/publisher-publish.s3.eu-central-1.amazonaws.com\/pb-brasil247\/swp\/jtjeq9\/media\/20211229201244_af5be3ee339e9d67db3742161ab05dd2f3d358bf8c3575b8c642caf72091a59d.png\" alt=\"www.brasil247.com - Alexander Gintsburg\" \/><\/picture><figcaption>Alexander Gintsburg (Foto: Evgeniy Odinokov\/POOL\/TASS)<\/figcaption><\/figure>\n<div class=\"article__text marginTop30\">\n<p><b>MOSCOU, TASS \u2013<\/b>\u00a0A vacina nasal contra a nova infec\u00e7\u00e3o por coronav\u00edrus estar\u00e1 em circula\u00e7\u00e3o civil e dispon\u00edvel para os russos em 3-4 meses, disse o diretor do Gamaleya Center Alexander Gintsburg \u00e0 ag\u00eancia TASS.<\/p>\n<p>\u201cA vacina nasal para a circula\u00e7\u00e3o civil estar\u00e1 dispon\u00edvel em 3-4 meses\u201d, disse o Diretor. Ser\u00e1 eficiente contra a nova cepa de coronav\u00edrus Omicron, disse Gintsburg. &#8220;Testes de laborat\u00f3rio mostram que o Sputnik V [vacina contra o coronav\u00edrus] protege contra o Omicron [cepa] em sua forma injet\u00e1vel comum e certamente ser\u00e1 eficiente na forma nasal&#8221;, acrescentou.<\/p>\n<p>Em outubro de 2021, o Minist\u00e9rio da Sa\u00fade da R\u00fassia concedeu autoriza\u00e7\u00e3o ao centro Gamaleya para a segunda fase dos ensaios cl\u00ednicos da vacina contra o coronav\u00edrus na forma de spray nasal.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Produto ser\u00e1 eficiente contra a variante \u00f4micron, diz Alexander Gintsburg, diretor do Instituto Gamaleya<\/p>\n","protected":false},"author":5,"featured_media":373027,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[2,12],"tags":[],"class_list":["post-376437","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cotidiano","category-saude"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/acaopopular.net\/jornal\/wp-content\/uploads\/2021\/11\/vacina-no-isopor.jpg","_links":{"self":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts\/376437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/comments?post=376437"}],"version-history":[{"count":0,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts\/376437\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/media\/373027"}],"wp:attachment":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/media?parent=376437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/categories?post=376437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/tags?post=376437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}